🇺🇸 FDA
Patent

US 9783572

Synthesis of syrbactin proteasome inhibitors

granted A61KA61K38/06A61K45/06

Quick answer

US patent 9783572 (Synthesis of syrbactin proteasome inhibitors) held by The Regents of the University of California expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/06, A61K45/06, A61P, A61P29/00